A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Komal Jhaveri, MD, FACP
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
East Melbourne, Australia
- Research Site
Westmead, Australia
- Research Site
Edegem, Belgium
- Research Site
Leuven, Belgium
- Research Site
Ottignies, Belgium
- Research Site
Goiânia, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
Porto Alegre, Brazil
- Research Site
São Paulo, Brazil
- Research Site
São Paulo, Brazil
- Research Site
Kelowna, British Columbia, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Villejuif, France
- Research Site
Monterrey, Mexico
- Research Site
Moscow, Russia
- Research Site
Moscow, Russia
- Research Site
Saint Petersburg, Russia
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Kaohsiung City, Taiwan
- Research Site
Taichung, Taiwan
- Research Site
Taipei, Taiwan
- Research Site
Taipei, Taiwan
- Research Site
Taipei, Taiwan
- Research Site
Taipei, Taiwan
- Research Site
Taoyuan, Taiwan
- Research Site
Commack, New York, United States
- Research Site
Harrison, New York, United States
- Research Site
New York, New York, United States
- Research Site
New York, New York, United States
- Research Site
Uniondale, New York, United States
- Research Site
Chapel Hill, North Carolina, United States
- Research Site
Chattanooga, Tennessee, United States
- Research Site
Germantown, Tennessee, United States
- Research Site
Fort Worth, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 17 Dec 2020
- Primary completion
- 16 Aug 2023
- Completion
- 16 Jun 2026
- Last update posted
- 17 Dec 2025
- Registered enrollment
- 138
- Registry id
- NCT04556773
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.